United States Hemoglobinopathies Industry Industry 2016 Deep Market Research Report
- QYR607633
- 138 Pages
- June 2016
- Pharmaceuticals
The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Hemoglobinopathies market analysis is provided for the United States markets including development trends, competitive landscape analysis, and key regions development status.
Development policies and plans are discussed as well as manufacturing processes and Bill of Materials cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins.
The report focuses on United States major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The Hemoglobinopathies industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered.
With 145 tables and figures the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
1 Industry Overview
1.1 Definition and Specifications of Hemoglobinopathies
1.1.1 Definition of Hemoglobinopathies
1.1.2 Specifications of Hemoglobinopathies
1.2 Classification of Hemoglobinopathies
1.2.1 Alpha Thalassemia
1.2.2 Beta thalassemia
1.2.3 Sickle Cell Disease
1.2.4 Hb Variants
1.3 Applications of Hemoglobinopathies
1.4 Industry Chain Structure of Hemoglobinopathies
1.5 Industry Overview of Hemoglobinopathies
1.6 Industry Policy Analysis of Hemoglobinopathies
1.7 Industry News Analysis of Hemoglobinopathies
2 Manufacturing Cost Structure Analysis of Hemoglobinopathies
2.1 Bill of Materials (BOM) of Hemoglobinopathies
2.2 BOM Price Analysis of Hemoglobinopathies
2.3 Labor Cost Analysis of Hemoglobinopathies
2.4 Depreciation Cost Analysis of Hemoglobinopathies
2.5 Manufacturing Cost Structure Analysis of Hemoglobinopathies
2.6 Manufacturing Process Analysis of Hemoglobinopathies
2.7 United States Price, Cost and Gross of Hemoglobinopathies 2011-2016
3 Technical Data and Manufacturing Plants Analysis
3.1 Capacity and Commercial Production Date of United States Key Manufacturers in 2015
3.2 Manufacturing Plants Distribution of United States Key Hemoglobinopathies Manufacturers in 2015
3.3 R&D Status and Technology Source of United States Hemoglobinopathies Key Manufacturers in 2015
3.4 Raw Materials Sources Analysis of United States Hemoglobinopathies Key Manufacturers in 2015
4 Production Analysis of Hemoglobinopathies by Regions, Type, and Applications
4.1 United States Production of Hemoglobinopathies by Regions 2011-2016
4.2 United States Production of Hemoglobinopathies by Type 2011-2016
4.3 United States Sales of Hemoglobinopathies by Applications 2011-2016
4.4 Price Analysis of United States Hemoglobinopathies Key Manufacturers in 2015
4.5 United States Capacity, Production, Import, Export, Sales, Price, Cost and Revenue of Hemoglobinopathies 2011-2016
5 Consumption Volume and Consumption Value Analysis of Hemoglobinopathies by Regions
5.1 United States Consumption Volume of Hemoglobinopathies by Regions 2011-2016
5.2 United States Consumption Value of Hemoglobinopathies by Regions 2011-2016
5.3 United States Consumption Price Analysis of Hemoglobinopathies by Regions 2011-2016
6 Analysis of Hemoglobinopathies Production, Supply, Sales and Market Status 2011-2016
6.1 Capacity, Production, Sales, and Revenue of Hemoglobinopathies 2011-2016
6.2 Production Market Share and Sales Market Share Analysis of Hemoglobinopathies 2014-2015
6.3 Sales Overview of Hemoglobinopathies 2011-2016
6.4 Supply, Consumption and Gap of Hemoglobinopathies 2011-2016
6.5 Import, Export and Consumption of Hemoglobinopathies 2011-2016
6.6 Cost, Price, Revenue and Gross Margin of Hemoglobinopathies 2011-2016
7 Analysis of Hemoglobinopathies Industry Key Manufacturers
7.1 Gamida Cell
7.1.1 Company Profile
7.1.2 Product Picture and Specifications
7.1.2.1 Type I
7.1.2.2 Type II
7.1.2.3 Type III
7.1.3 Capacity, Production, Price, Cost, Gross and Revenue
7.1.4 Contact Information
7.2 Alnylam Pharmaceuticals
7.2.1 Company Profile
7.2.2 Product Picture and Specifications
7.2.2.1 Type I
7.2.2.2 Type II
7.2.2.3 Type III
7.2.3 Capacity, Production, Price, Cost, Gross and Revenue
7.2.4 Contact Information
7.3 Biogen Idec
7.3.1 Company Profile
7.3.2 Product Picture and Specifications
7.3.2.1 Type I
7.3.2.2 Type II
7.3.2.3 Type III
7.3.3 Capacity, Production, Price, Cost, Gross and Revenue
7.3.4 Contact Information
7.4 Sangamo BioSciences Inc.
7.4.1 Company Profile
7.4.2 Product Picture and Specifications
7.4.2.1 Type I
7.4.2.2 Type II
7.4.2.3 Type III
7.4.3 Capacity, Production, Price, Cost, Gross and Revenue
7.4.4 Contact Information
7.5 Genetix Pharmaceuticals
7.5.1 Company Profile
7.5.2 Product Picture and Specifications
7.5.2.1 Type I
7.5.2.2 Type II
7.5.2.3 Type III
7.5.3 Capacity, Production, Price, Cost, Gross and Revenue
7.5.4 Contact Information
7.6 Global Blood Therapeutics Inc
7.6.1 Company Profile
7.6.2 Product Picture and Specifications
7.6.2.1 Type I
7.6.2.2 Type II
7.6.2.3 Type III
7.6.3 Capacity, Production, Price, Cost, Gross and Revenue
7.6.4 Contact Information
7.7 Mast Therapeutics
7.7.1 Company Profile
7.7.2 Product Picture and Specifications
7.7.2.1 Type I
7.7.2.2 Type II
7.7.2.3 Type III
7.7.3 Capacity, Production, Price, Cost, Gross and Revenue
7.7.4 Contact Information
7.8 Prolong Pharmaceuticals
7.8.1 Company Profile
7.8.2 Product Picture and Specifications
7.8.2.1 Type I
7.8.2.2 Type II
7.8.2.3 Type III
7.8.3 Capacity, Production, Price, Cost, Gross and Revenue
7.8.4 Contact Information
7.9 Celgene Corporation
7.9.1 Company Profile
7.9.2 Product Picture and Specifications
7.9.2.1 Type I
7.9.2.2 Type II
7.9.2.3 Type III
7.9.3 Capacity, Production, Price, Cost, Gross and Revenue
7.9.4 Contact Information
7.10 HemaQuest Pharmaceuticals
7.10.1 Company Profile
7.10.2 Product Picture and Specifications
7.10.2.1 Type I
7.10.2.2 Type II
7.10.2.3 Type III
7.10.3 Capacity, Production, Price, Cost, Gross and Revenue
7.10.4 Contact Information
8 Price and Gross Margin Analysis
8.1 Analysis of Price
8.2 Gross Margin Analysis
8.3 Price Comparison by Regions
8.4 Price Analysis of Different Hemoglobinopathies Product Types
8.5 Market Share Analysis of Different Hemoglobinopathies Price Levels
8.6 Gross Margin Analysis of Different Hemoglobinopathies Applications
9 Marketing Trader or Distributor Analysis of Hemoglobinopathies
9.1 Marketing Channels Status of Hemoglobinopathies
9.2 Traders or Distributors of Hemoglobinopathies with Contact Information
9.3 Ex-work Price, Channel Price and End Buyer Price Analysis of Hemoglobinopathies
9.4 United States Import, Export and Trade Analysis of Hemoglobinopathies
10 Development Trend of Hemoglobinopathies Industry 2016-2021
10.1 Capacity and Production Overview of Hemoglobinopathies 2016-2021
10.2 Production Market Share by Product Types of Hemoglobinopathies 2016-2021
10.3 Sales and Sales Revenue Overview of Hemoglobinopathies 2016-2021
10.4 United States Sales of Hemoglobinopathies by Applications 2016-2021
10.5 Import, Export and Consumption of Hemoglobinopathies 2016-2021
10.6 Cost, Price, Revenue and Gross Margin of Hemoglobinopathies 2016-2021
11 Industry Chain Suppliers of Hemoglobinopathies with Contact Information
11.1 Major Raw Materials Suppliers of Hemoglobinopathies with Contact Information
11.2 Manufacturing Equipment Suppliers of Hemoglobinopathies with Contact Information
11.3 Major Players of Hemoglobinopathies with Contact Information
11.4 Key Consumers of Hemoglobinopathies with Contact Information
11.5 Supply Chain Relationship Analysis of Hemoglobinopathies
12 New Project Investment Feasibility Analysis of Hemoglobinopathies
12.1 New Project SWOT Analysis of Hemoglobinopathies
12.2 New Project Investment Feasibility Analysis of Hemoglobinopathies
13 Conclusion of the United States Hemoglobinopathies Industry 2016 Market Research Report
Figure Picture of Hemoglobinopathies
Table Product Specifications of Hemoglobinopathies
Table Classification of Hemoglobinopathies
Figure United States Sales Market Share of Hemoglobinopathies by Product Types in 2015
Table Applications of Hemoglobinopathies
Figure United States Sales Market Share of Hemoglobinopathies by Applications in 2015
Figure Industry Chain Structure of Hemoglobinopathies
Table United States Industry Overview of Hemoglobinopathies
Table Industry Policy of Hemoglobinopathies
Table Industry News List of Hemoglobinopathies
Table Bill of Materials (BOM) of Hemoglobinopathies
Table Bill of Materials (BOM) Price of Hemoglobinopathies
Table Labor Cost of Hemoglobinopathies
Table Depreciation Cost of Hemoglobinopathies
Table Manufacturing Cost Structure Analysis of Hemoglobinopathies in 2015
Figure Manufacturing Process Analysis of Hemoglobinopathies
Table United States Price Analysis of Hemoglobinopathies 2011-2016 (USD/Unit)
Table United States Cost Analysis of Hemoglobinopathies 2011-2016 (USD/Unit)
Table United States Gross Analysis of Hemoglobinopathies 2011-2016
Table Capacity (Unit) and Commercial Production Date of United States Hemoglobinopathies Key Manufacturers in 2015
Table Manufacturing Plants Distribution of United States Key Hemoglobinopathies Manufacturers in 2015
Table R&D Status and Technology Source of United States Hemoglobinopathies Key Manufacturers in 2015
Table Raw Materials Sources Analysis of United States and United States Hemoglobinopathies Key Manufacturers in 2015
Table United States Production of Hemoglobinopathies by Regions 2011-2016 (Unit)
Table United States Production Market Share of Hemoglobinopathies by Regions 2011-2016
Figure United States Production Market Share of Hemoglobinopathies by Regions in 2014
Figure United States Production Market Share of Hemoglobinopathies by Regions in 2015
Table United States Production of Hemoglobinopathies by Types in 2011-2016 (Unit)
Table United States Production Market Share of Hemoglobinopathies by Type in 2011-2016
Figure United States Production Market Share of Hemoglobinopathies by Type in 2014
Figure United States Production Market Share of Hemoglobinopathies by Type in 2015
Table United States Sales of Hemoglobinopathies by Applications 2011-2016 (Unit)
Table United States Production Market Share of Hemoglobinopathies by Applications 2011-2016
Figure United States Production Market Share of Hemoglobinopathies by Applications in 2014
Figure United States Production Market Share of Hemoglobinopathies by Applications in 2015
Table Price Comparison of United States Hemoglobinopathies Key Manufacturers in 2015 (USD/Unit)
Table United States Capacity, Production, Import Export Sales Price , Cost and Revenue (M USD) of Hemoglobinopathies 2011-2016
Table United States Consumption Volume of Hemoglobinopathies by Regions 2011-2016 (Unit)
Table United States Consumption Volume Market Share of Hemoglobinopathies by Regions 2011-2016
Figure United States Consumption Volume Market Share of Hemoglobinopathies by Regions in 2014
Figure United States Consumption Volume Market Share of Hemoglobinopathies by Regions in 2015
Table United States Consumption Value of Hemoglobinopathies by Regions 2011-2016 (M USD)
Table United States Consumption Value Market Share of Hemoglobinopathies by Regions 2011-2016
Figure United States Consumption Value Market Share of Hemoglobinopathies by Regions in 2014
Figure United States Consumption Value Market Share of Hemoglobinopathies by Regions in 2015
Table Consumption Price of Hemoglobinopathies by Regions 2011-2016 (USD/Unit)
Table United States and Major Manufacturers Capacity of Hemoglobinopathies 2011-2016 (Unit)
Table United States Capacity Market Share of Major Hemoglobinopathies Manufacturers 2011-2016
Table United States and Major Manufacturers Production of Hemoglobinopathies 2011-2016 (Unit)
Table United States Production Market Share of Major Hemoglobinopathies Manufacturers 2011-2016
Table United States and Major Manufacturers Sales of Hemoglobinopathies 2011-2016 (Unit)
Table United States Sales Market Share of Major Hemoglobinopathies Manufacturers 2011-2016
Table United States and Major Manufacturers Sales Revenue of Hemoglobinopathies 2011-2016 (M USD)
Table United States Sales Revenue Market Share of Major Hemoglobinopathies Manufacturers 2011-2016
Figure United States Capacity (Unit), Production (Unit) and Growth Rate of Hemoglobinopathies 2011-2016
Figure United States Capacity Utilization Rate of Hemoglobinopathies 2011-2016
Figure United States Sales Revenue (M USD) and Growth Rate of Hemoglobinopathies 2011-2016
Figure United States Production Market Share of Major Hemoglobinopathies Manufacturers in 2014
Figure United States Production Market Share of Major Hemoglobinopathies Manufacturers in 2015
Figure United States Sales Market Share of Major Hemoglobinopathies Manufacturers in 2014
Figure United States Sales Market Share of Major Hemoglobinopathies Manufacturers in 2015
Figure United States Sales (Unit) and Growth Rate of Hemoglobinopathies 2011-2016
Table United States Supply, Consumption and Gap of Hemoglobinopathies 2011-2016 (Unit)
Table United States Import, Export and Consumption of Hemoglobinopathies 2011-2016 (Unit)
Table Price of United States Hemoglobinopathies Major Manufacturers 2011-2016 (USD/Unit)
Table Gross Margin of United States Hemoglobinopathies Major Manufacturers 2011-2016
Table United States and Major Manufacturers Revenue of Hemoglobinopathies 2011-2016 (M USD)
Table United States Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Revenue (M USD) and Gross Margin of Hemoglobinopathies 2011-2016
Table Gamida Cell Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Hemoglobinopathies Picture and Specifications of Gamida Cell
Table Hemoglobinopathies Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Gamida Cell 2011-2016
Figure Hemoglobinopathies Capacity (Unit), Production (Unit) and Growth Rate of Gamida Cell 2011-2016
Figure Hemoglobinopathies Production (Unit) and United States Market Share of Gamida Cell 2011-2016
Table Gamida Cell Hemoglobinopathies SWOT Analysis
Table Alnylam Pharmaceuticals Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Hemoglobinopathies Picture and Specifications of Alnylam Pharmaceuticals
Table Hemoglobinopathies Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Alnylam Pharmaceuticals 2011-2016
Figure Hemoglobinopathies Capacity (Unit), Production (Unit) and Growth Rate of Alnylam Pharmaceuticals 2011-2016
Figure Hemoglobinopathies Production (Unit) and United States Market Share of Alnylam Pharmaceuticals 2011-2016
Table Alnylam Pharmaceuticals Hemoglobinopathies SWOT Analysis
Table Biogen Idec Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Hemoglobinopathies Picture and Specifications of Biogen Idec
Table Hemoglobinopathies Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Biogen Idec 2011-2016
Figure Hemoglobinopathies Capacity (Unit), Production (Unit) and Growth Rate of Biogen Idec 2011-2016
Figure Hemoglobinopathies Production (Unit) and United States Market Share of Biogen Idec 2011-2016
Table Biogen Idec Hemoglobinopathies SWOT Analysis
Table Sangamo BioSciences Inc. Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Hemoglobinopathies Picture and Specifications of Sangamo BioSciences Inc.
Table Hemoglobinopathies Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Sangamo BioSciences Inc. 2011-2016
Figure Hemoglobinopathies Capacity (Unit), Production (Unit) and Growth Rate of Sangamo BioSciences Inc. 2011-2016
Figure Hemoglobinopathies Production (Unit) and United States Market Share of Sangamo BioSciences Inc. 2011-2016
Table Sangamo BioSciences Inc. Hemoglobinopathies SWOT Analysis
Table Genetix Pharmaceuticals Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Hemoglobinopathies Picture and Specifications of Genetix Pharmaceuticals
Table Hemoglobinopathies Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Genetix Pharmaceuticals 2011-2016
Figure Hemoglobinopathies Capacity (Unit), Production (Unit) and Growth Rate of Genetix Pharmaceuticals 2011-2016
Figure Hemoglobinopathies Production (Unit) and United States Market Share of Genetix Pharmaceuticals 2011-2016
Table Genetix Pharmaceuticals Hemoglobinopathies SWOT Analysis
Table Global Blood Therapeutics Inc Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Hemoglobinopathies Picture and Specifications of Global Blood Therapeutics Inc
Table Hemoglobinopathies Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Global Blood Therapeutics Inc 2011-2016
Figure Hemoglobinopathies Capacity (Unit), Production (Unit) and Growth Rate of Global Blood Therapeutics Inc 2011-2016
Figure Hemoglobinopathies Production (Unit) and United States Market Share of Global Blood Therapeutics Inc 2011-2016
Table Global Blood Therapeutics Inc Hemoglobinopathies SWOT Analysis
Table Mast Therapeutics Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Hemoglobinopathies Picture and Specifications of Mast Therapeutics
Table Hemoglobinopathies Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Mast Therapeutics 2011-2016
Figure Hemoglobinopathies Capacity (Unit), Production (Unit) and Growth Rate of Mast Therapeutics 2011-2016
Figure Hemoglobinopathies Production (Unit) and United States Market Share of Mast Therapeutics 2011-2016
Table Mast Therapeutics Hemoglobinopathies SWOT Analysis
Table Prolong Pharmaceuticals Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Hemoglobinopathies Picture and Specifications of Prolong Pharmaceuticals
Table Hemoglobinopathies Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Prolong Pharmaceuticals 2011-2016
Figure Hemoglobinopathies Capacity (Unit), Production (Unit) and Growth Rate of Prolong Pharmaceuticals 2011-2016
Figure Hemoglobinopathies Production (Unit) and United States Market Share of Prolong Pharmaceuticals 2011-2016
Table Prolong Pharmaceuticals Hemoglobinopathies SWOT Analysis
Table Celgene Corporation Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Hemoglobinopathies Picture and Specifications of Celgene Corporation
Table Hemoglobinopathies Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Celgene Corporation 2011-2016
Figure Hemoglobinopathies Capacity (Unit), Production (Unit) and Growth Rate of Celgene Corporation 2011-2016
Figure Hemoglobinopathies Production (Unit) and United States Market Share of Celgene Corporation 2011-2016
Table Celgene Corporation Hemoglobinopathies SWOT Analysis
Table HemaQuest Pharmaceuticals Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Hemoglobinopathies Picture and Specifications of HemaQuest Pharmaceuticals
Table Hemoglobinopathies Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of HemaQuest Pharmaceuticals 2011-2016
Figure Hemoglobinopathies Capacity (Unit), Production (Unit) and Growth Rate of HemaQuest Pharmaceuticals 2011-2016
Figure Hemoglobinopathies Production (Unit) and United States Market Share of HemaQuest Pharmaceuticals 2011-2016
Table HemaQuest Pharmaceuticals Hemoglobinopathies SWOT Analysis
Table Hemoglobinopathies Price by Regions 2011-2016
Table Hemoglobinopathies Price by Product Types 2011-2016
Table Hemoglobinopathies Price by Companies 2011-2016
Table Hemoglobinopathies Gross Margin by Companies 2011-2016
Table Price Comparison of Hemoglobinopathies by Regions 2011-2016 (USD/Unit)
Table Price of Different Hemoglobinopathies Product Types (USD/Unit)
Table Market Share of Different Hemoglobinopathies Price Level
Table Gross Margin of Different Hemoglobinopathies Applications
Table Marketing Channels Status of Hemoglobinopathies
Table Traders or Distributors of Hemoglobinopathies with Contact Information
Table Ex-work Price, Channel Price and End Buyer Price of Hemoglobinopathies (USD/Unit) in 2015
Table United States Import, Export, and Trade of Hemoglobinopathies (Unit)
Figure United States Capacity (Unit), Production (Unit) and Growth Rate of Hemoglobinopathies 2016-2021
Figure United States Capacity Utilization Rate of Hemoglobinopathies 2016-2021
Table United States Hemoglobinopathies Production by Type 2016-2021 (Unit)
Table United States Hemoglobinopathies Production Market Share by Type 2016-2021
Figure United States Production Market Share of Hemoglobinopathies by Type in 2021
Figure United States Sales (Unit) and Growth Rate of Hemoglobinopathies 2016-2021
Figure United States Sales Revenue (Million USD) and Growth Rate of Hemoglobinopathies 2016-2021
Figure United States Sales of Hemoglobinopathies by Applications 2016-2021 (Unit)
Table United States Production Market Share of Hemoglobinopathies by Applications 2016-2021
Figure United States Production Market Share of Hemoglobinopathies by Applications in 2021
Table United States Production, Import, Export and Consumption of Hemoglobinopathies 2016-2021 (Unit)
Table United States Production (Unit), Price (USD/Unit), Cost (USD/Unit), Revenue (M USD) and Gross Margin of Hemoglobinopathies 2016-2021
Table Major Raw Materials Suppliers of Hemoglobinopathies with Contact Information
Table Manufacturing Equipment Suppliers of Hemoglobinopathies with Contact Information
Table Major Players of Hemoglobinopathies with Contact Information
Table Key Consumers of Hemoglobinopathies with Contact Information
Table Supply Chain Relationship Analysis of Hemoglobinopathies
Table New Project SWOT Analysis of Hemoglobinopathies
Table New Project Investment Feasibility Analysis of Hemoglobinopathies
Table Part of Interviewees Record List
Similar Reports
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
- Publish Date: November 14, 2017
- $5370
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
- Publish Date: July 20, 2017
- $5370
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...
- Publish Date: April 24, 2017
- $5370
